Rhenman & Partners Asset Management AB - VIKING THERAPEUTICS INC ownership

VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 148 filers reported holding VIKING THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.

Quarter-by-quarter ownership
Rhenman & Partners Asset Management AB ownership history of VIKING THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,992,600
-31.7%
180,0000.0%0.22%
-30.2%
Q2 2023$2,917,800
-6.5%
180,0000.0%0.31%
-9.9%
Q1 2023$3,119,400
+233.3%
180,000
-10.0%
0.34%
+161.1%
Q1 2020$936,000
-41.6%
200,0000.0%0.13%
-25.6%
Q4 2019$1,604,000
+16.6%
200,0000.0%0.18%
+2.3%
Q3 2019$1,376,000
-43.1%
200,000
-31.4%
0.17%
-35.3%
Q2 2019$2,419,000291,4990.27%
Other shareholders
VIKING THERAPEUTICS INC shareholders Q4 2019
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 450,900$2,624,0000.85%
Sio Capital Management, LLC 709,780$4,131,0000.82%
KNOTT DAVID M 218,102$1,269,0000.74%
ArrowMark Colorado Holdings LLC 7,988,635$46,494,0000.44%
Park West Asset Management LLC 1,457,507$8,483,0000.33%
VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. 1,657$10,0000.18%
Virtus ETF Advisers LLC 42,507$247,0000.13%
Cornerstone Capital, Inc. 125,465$730,0000.10%
L & S Advisors Inc 114,988$669,0000.09%
EXANE DERIVATIVES 44,877$261,170,0000.08%
View complete list of VIKING THERAPEUTICS INC shareholders